UFP Technologies (UFPT) Stock Analysis & AI Equity Report

Medical - Devices USD Explore free reports

UFP Technologies (UFPT) overview

UFP Technologies (UFPT) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 603m and operating profit of USD 92.3m; the year-end share price was 222.03 USD and market capitalisation was USD 1,713m. UFP Technologies is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get UFP Technologies's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 424mFY 2025
Share price222.03 USDFY 2025 year end
RevenueUSD 603mFY 2025
Operating profitUSD 92.3mFY 2025
Net earningsUSD 68.3mFY 2025
Market capitalisationUSD 1,713mFY 2025 year end

About UFP Technologies

UFP Technologies develops and manufactures single-use and single-patient medical devices and components, often customized to customer specifications. Its products serve minimally invasive surgery, infection prevention, wound care, wearables, and orthopedic applications. Examples include surgical drapes, patient handling products, procedure disposables, medical-device packaging, orthopedic implant packaging, cardiac implant components, catheter dispenser coils, and products used in biopharmaceutical drug manufacturing. Its customers include medical device manufacturers.

Generate the UFP Technologies report

UFP Technologies is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for UFP Technologies and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on UFP Technologies

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.